Form 8-K - Current report:
SEC Accession No. 0001005286-25-000133
Filing Date
2025-09-26
Accepted
2025-09-26 16:33:59
Documents
12
Period of Report
2025-09-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K lfcr-20250922.htm   iXBRL 8-K 27432
  Complete submission text file 0001005286-25-000133.txt   144671

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfcr-20250922.xsd EX-101.SCH 1882
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfcr-20250922_lab.xml EX-101.LAB 21885
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfcr-20250922_pre.xml EX-101.PRE 12603
14 EXTRACTED XBRL INSTANCE DOCUMENT lfcr-20250922_htm.xml XML 2718
Mailing Address 3515 LYMAN BOULEVARD CHASKA MN 55318
Business Address 3515 LYMAN BOULEVARD CHASKA MN 55318 9523684300
LIFECORE BIOMEDICAL, INC. \DE\ (Filer) CIK: 0001005286 (see all company filings)

EIN.: 943025618 | State of Incorp.: DE | Fiscal Year End: 0525
Type: 8-K | Act: 34 | File No.: 000-27446 | Film No.: 251351030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)